pt001
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2009 (NCT00871182)
Timeline
Indications
Mechanism of action
- Programmed cell death 1 ligand 2ACTIVATOR
PDCD1LG2 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pt001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01587079 | Phase 2 | Apr 1, 2012 | Pearl Therapeutics |
| NCT01566773 | Phase 2 | Mar 1, 2012 | Pearl Therapeutics |
| NCT01349816 | Phase 2 | Jun 1, 2011 | Pearl Therapeutics |
| NCT01349803 | Phase 2 | May 1, 2011 | Pearl Therapeutics |
| NCT01350128 | Phase 2 | May 1, 2011 | Pearl Therapeutics |
| NCT01085045 | Phase 2 | Mar 1, 2010 | Pearl Therapeutics |
| NCT00893971 | Phase 1 | May 1, 2009 | Pearl Therapeutics |
| NCT00871182 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2009 | Pearl Therapeutics |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pearl Therapeutics | For profit | 8 | 8 | 2 | 2009 |
1 organizations
Page 1 / 1